Cite
HARVARD Citation
Savarirayan, R. et al. (2020). Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial. Lancet. 396 (10252), pp. 684-692. [Online].